Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma

Xiaoyan Wang, Shaobo Zhang, Gregory T. MacLennan, Katharina Biermann, Richard S. Foster, Stephen D. Beck, Liang Cheng

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Testicular cancer is the most common cancer in young male patients. The combination of cisplatin-based chemotherapy and surgery has resulted in high cure rates. However, a small percentage of patients have cancers that are refractory to chemotherapy; treatment options for these patients are limited, and their prognosis is generally poor. Further studies are needed to explore the molecular pathogenesis pathways and potential targets of therapy for this group of highly aggressive tumors. We analyzed 21 patients who presented with metastatic embryonal carcinoma, were treated with chemotherapy, and subsequently underwent retroperitoneal lymph node dissection. Immunostaining for epidermal growth factor receptor (EGFR) was performed on paraffin-embedded tissue sections containing tumor from these specimens, using the avidin-biotin-peroxidase method. EGFR gene amplification was performed by interphase fluorescence in situ hybridization (FISH). Immunohistochemically, 9 of 21 cases (43%) demonstrated positive EGFR staining; 12 of 21 cases (57%) had absent or very limited EGFR expression. FISH revealed EGFR amplification in 1 case (5%), polysomy in 15 of 21 cases (71%), and normal disomy pattern in 5 of 21 cases (24%). A significant correlation between EGFR protein expression level and its chromosome polysomy/amplification was established (P=0.02). Our study showed that EGFR protein is frequently expressed in a subset of patients with chemorefractory metastatic embryonal carcinoma. EGFR chromosomal polysomy/amplification may be one of the mechanisms that cause increased EGFR protein expression, and could potentially be used as indication for anti-EGFR therapy.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalModern Pathology
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Embryonal Carcinoma
erbB-1 Genes
Gene Amplification
Epidermal Growth Factor Receptor
Proteins
Fluorescence In Situ Hybridization
Drug Therapy
Neoplasms
Avidin
Interphase
Testicular Neoplasms
Group Psychotherapy
Biotin
Lymph Node Excision
Paraffin
Cisplatin
Peroxidase
Chromosomes
Staining and Labeling

Keywords

  • Epidermal growth factor receptor
  • Germ cell tumor
  • Metastatic embryonal carcinoma
  • Molecular markers
  • Prognosis
  • Testis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma. / Wang, Xiaoyan; Zhang, Shaobo; MacLennan, Gregory T.; Biermann, Katharina; Foster, Richard S.; Beck, Stephen D.; Cheng, Liang.

In: Modern Pathology, Vol. 22, No. 1, 01.01.2009, p. 7-12.

Research output: Contribution to journalArticle

@article{65e6dafeb5d6404a8847a016995186e4,
title = "Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma",
abstract = "Testicular cancer is the most common cancer in young male patients. The combination of cisplatin-based chemotherapy and surgery has resulted in high cure rates. However, a small percentage of patients have cancers that are refractory to chemotherapy; treatment options for these patients are limited, and their prognosis is generally poor. Further studies are needed to explore the molecular pathogenesis pathways and potential targets of therapy for this group of highly aggressive tumors. We analyzed 21 patients who presented with metastatic embryonal carcinoma, were treated with chemotherapy, and subsequently underwent retroperitoneal lymph node dissection. Immunostaining for epidermal growth factor receptor (EGFR) was performed on paraffin-embedded tissue sections containing tumor from these specimens, using the avidin-biotin-peroxidase method. EGFR gene amplification was performed by interphase fluorescence in situ hybridization (FISH). Immunohistochemically, 9 of 21 cases (43{\%}) demonstrated positive EGFR staining; 12 of 21 cases (57{\%}) had absent or very limited EGFR expression. FISH revealed EGFR amplification in 1 case (5{\%}), polysomy in 15 of 21 cases (71{\%}), and normal disomy pattern in 5 of 21 cases (24{\%}). A significant correlation between EGFR protein expression level and its chromosome polysomy/amplification was established (P=0.02). Our study showed that EGFR protein is frequently expressed in a subset of patients with chemorefractory metastatic embryonal carcinoma. EGFR chromosomal polysomy/amplification may be one of the mechanisms that cause increased EGFR protein expression, and could potentially be used as indication for anti-EGFR therapy.",
keywords = "Epidermal growth factor receptor, Germ cell tumor, Metastatic embryonal carcinoma, Molecular markers, Prognosis, Testis",
author = "Xiaoyan Wang and Shaobo Zhang and MacLennan, {Gregory T.} and Katharina Biermann and Foster, {Richard S.} and Beck, {Stephen D.} and Liang Cheng",
year = "2009",
month = "1",
day = "1",
doi = "10.1038/modpathol.2008.133",
language = "English (US)",
volume = "22",
pages = "7--12",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma

AU - Wang, Xiaoyan

AU - Zhang, Shaobo

AU - MacLennan, Gregory T.

AU - Biermann, Katharina

AU - Foster, Richard S.

AU - Beck, Stephen D.

AU - Cheng, Liang

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Testicular cancer is the most common cancer in young male patients. The combination of cisplatin-based chemotherapy and surgery has resulted in high cure rates. However, a small percentage of patients have cancers that are refractory to chemotherapy; treatment options for these patients are limited, and their prognosis is generally poor. Further studies are needed to explore the molecular pathogenesis pathways and potential targets of therapy for this group of highly aggressive tumors. We analyzed 21 patients who presented with metastatic embryonal carcinoma, were treated with chemotherapy, and subsequently underwent retroperitoneal lymph node dissection. Immunostaining for epidermal growth factor receptor (EGFR) was performed on paraffin-embedded tissue sections containing tumor from these specimens, using the avidin-biotin-peroxidase method. EGFR gene amplification was performed by interphase fluorescence in situ hybridization (FISH). Immunohistochemically, 9 of 21 cases (43%) demonstrated positive EGFR staining; 12 of 21 cases (57%) had absent or very limited EGFR expression. FISH revealed EGFR amplification in 1 case (5%), polysomy in 15 of 21 cases (71%), and normal disomy pattern in 5 of 21 cases (24%). A significant correlation between EGFR protein expression level and its chromosome polysomy/amplification was established (P=0.02). Our study showed that EGFR protein is frequently expressed in a subset of patients with chemorefractory metastatic embryonal carcinoma. EGFR chromosomal polysomy/amplification may be one of the mechanisms that cause increased EGFR protein expression, and could potentially be used as indication for anti-EGFR therapy.

AB - Testicular cancer is the most common cancer in young male patients. The combination of cisplatin-based chemotherapy and surgery has resulted in high cure rates. However, a small percentage of patients have cancers that are refractory to chemotherapy; treatment options for these patients are limited, and their prognosis is generally poor. Further studies are needed to explore the molecular pathogenesis pathways and potential targets of therapy for this group of highly aggressive tumors. We analyzed 21 patients who presented with metastatic embryonal carcinoma, were treated with chemotherapy, and subsequently underwent retroperitoneal lymph node dissection. Immunostaining for epidermal growth factor receptor (EGFR) was performed on paraffin-embedded tissue sections containing tumor from these specimens, using the avidin-biotin-peroxidase method. EGFR gene amplification was performed by interphase fluorescence in situ hybridization (FISH). Immunohistochemically, 9 of 21 cases (43%) demonstrated positive EGFR staining; 12 of 21 cases (57%) had absent or very limited EGFR expression. FISH revealed EGFR amplification in 1 case (5%), polysomy in 15 of 21 cases (71%), and normal disomy pattern in 5 of 21 cases (24%). A significant correlation between EGFR protein expression level and its chromosome polysomy/amplification was established (P=0.02). Our study showed that EGFR protein is frequently expressed in a subset of patients with chemorefractory metastatic embryonal carcinoma. EGFR chromosomal polysomy/amplification may be one of the mechanisms that cause increased EGFR protein expression, and could potentially be used as indication for anti-EGFR therapy.

KW - Epidermal growth factor receptor

KW - Germ cell tumor

KW - Metastatic embryonal carcinoma

KW - Molecular markers

KW - Prognosis

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=58149147488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149147488&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2008.133

DO - 10.1038/modpathol.2008.133

M3 - Article

C2 - 18660793

AN - SCOPUS:58149147488

VL - 22

SP - 7

EP - 12

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 1

ER -